Dr. Mark S. Godec is a Rockville, Maryland based neurologist who is specialized in Neurology. Active license number of Dr. Mark S. Godec is D37620 for Neurology in Maryland. His current practice location is 11140 Rockville Pike, #216, Rockville. Patients can reach him at 703-918-9365 or can fax him at 703-991-8800. Dr. Mark S. Godec is M.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1194943464. Dr. Mark S. Godec specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Mark S. Godec speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1194943464
NPI Enumeration Date:
23 Apr, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Mark S. Godec are as mentioned below.
License Number
Specialization
State
Status
D37620
Neurology
Maryland
Primary
0101235917
Neurology
Virginia
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Mark S. Godec 4431 Sleaford Rd, Annandale, Virginia
Zip:
22003-3925
Phone Number:
703-918-9365
Fax Number:
703-991-8800
Patients can reach Dr. Mark S. Godec at 11140 Rockville Pike, #216, Rockville, Maryland or can call to book an appointment on 703-918-9365.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.